Croissy-Beaubourg, March 9, 2020, 6:00 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has CE marked the first four i-Tracker® test kits…
Croissy-Beaubourg, February 19, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has been actively involved in the establishment and validation of a new World Health…
TRACKER, a comprehensive range on the market allowing all patients treated with Infliximab to be monitored Croissy-Beaubourg, February 13, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics…